2017-11-02T13:19:52-05:00 2016-12-31 231406493 MORISON COGEN LLP 484 NORRISTOWN RD STE 100 BLUE BELL PA 19422 990 2016-01-01 271536314 NCCN FOUNDATION NCCN 2156900300 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 LISA KIMBRO CHIEF FINANCIAL OFFICER 2156900300 2017-10-25 1 JOSEPH M KISTNER CPA P00157086 2674403000 100.11.134.178 2017-10-25 10:33:22 ED P E76F31B73F45A17F1177B762FD3E125090D17AB6 040CE4D7E9EA10F7EB01B02D67A6D27287D33504 2016 2021-01-29 14:40:06Z ROBERT W CARLSON MD 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 1898624 0 X WWW.NCCN.ORG X 2009 DE THROUGH PHILANTHROPY, THE NCCN FOUNDATION EMPOWERS PEOPLE THROUGH KNOWLEDGE AND ADVANCES THE MISSION OF NCCN TO IMPROVE THE QUALITY, EFFECTIVENESS, AND EFFICIENCY OF CANCER CARE, SO THAT PATIENTS CAN LIVE BETTER LIVES. 15 15 0 0 0 0 2372949 1889762 0 5645 904 907 1001 2310 2374854 1898624 825000 875000 0 0 479969 522972 0 0 148693 591348 1142318 1896317 2540290 478537 -641666 3490920 2999124 189363 339233 3301557 2659891 THROUGH PHILANTHROPY, THE NCCN FOUNDATION EMPOWERS PEOPLE THROUGH KNOWLEDGE AND ADVANCES THE MISSION OF NCCN TO IMPROVE THE QUALITY, EFFECTIVENESS, AND EFFICIENCY OF CANCER CARE, SO THAT PATIENTS CAN LIVE BETTER LIVES. 0 0 1079492 7955 TRANSLATE THE NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY FOR CLINICAL PROVIDERS INTO GUIDELINES WRITTEN FOR A PATIENT AUDIENCE. DISTRIBUTION OF THESE NCCN GUIDELINES FOR PATIENTS. 951331 875000 DEVELOP A RESEARCH GRANT PROGRAM TO ENCOURAGE AND ASSIST YOUNG INVESTIGATORS, NURSES, AND OTHERS TO CONDUCT INNOVATIVE AND COLLABORATIVE RESEARCH IN CLINICAL ONCOLOGY AT NCCN MEMBER INSTITUTIONS. 13846 GENERAL MISSION SUPPORT FOR NCCN FOUNDATION TO CONTINUE ITS MISSION AND ADVANCE THE MISSION OF NCCN TO IMPROVE THE QUALITY, EFFECTIVENESS, AND EFFICIENCY OF CARE TO PATIENTS WITH CANCER. 2044669 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 15 15 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X LISA KIMBRO 2156900300 275 COMMERCE DRIVE SUITE 300 FORT WASHINGTON PA 19034 ELLEN O TAUSCHER CHAIR 1.00 X 0 0 0 MICHAEL PARISI MBA MA VICE CHAIR 1.00 X 0 0 0 JACK GENTILE SECRETARY 1.00 X 0 0 0 RAY LYNCH CPA MBA TREASURER 1.00 X 0 0 0 AL B BENSON III MD DIRECTOR 1.00 X 0 0 0 GENA COOK DIRECTOR 1.00 X 0 0 0 BRIAN GAROFALO DIRECTOR 1.00 X 0 0 0 DEBORAH MOROSINI MD DIRECTOR 1.00 X 0 0 0 DENISE REINKE MS NP DIRECTOR 1.00 X 0 0 0 ROBERT C YOUNG MD DIRECTOR 1.00 X 0 0 0 THOMAS A D'AMICO MD DIRECTOR 1.00 X 0 0 0 JOSHUA H BILENKER MD DIRECTOR 1.00 X 0 0 0 HEATHER J KOPECKY PHD MBA DIRECTOR 1.00 X 0 0 0 MARC SAMUELS JD MPH DIRECTOR 1.00 X 0 0 0 SUSAN STEIN MPH DIRECTOR 1.00 X 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 2.00 40.00 X 0 713849 62426 GARY WEYHMULLER CHIEF OPERATING OFFICER 2.00 40.00 X 0 408816 68426 LISA KIMBRO CHIEF FINANCIAL OFFICER 2.00 40.00 X 0 316900 51021 MARCIE REEDER EXECUTIVE DIRECTOR 40.00 40.00 X 0 105080 44703 LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 1.00 40.00 X 0 273209 67421 EILEEN BOSCIA CONTROLLER 4.00 40.00 X 0 178445 23780 SUE MOST DIRECTOR, CLINICAL OPERATIONS 2.00 40.00 X 0 152830 33043 0 2149129 350820 0 0 1 0 NATIONAL COMPREHENSIVE CANCER NETWORK 275 COMMERCE DRIVE SUITE 300 FORT WASHINGTON PA 19034 PATIENT GUIDELINES WRITING/ART 1850110 JOHNS HOPKINS UNIVERSITY 1550 ORLEANS ST - 5M44 BALTIMORE MD 21231 RESEARCH 150000 REGENTS OF THE UNIV OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 481091274 RESEARCH 150000 MASS GENERAL HOSPITAL - RESEARCH PO BOX 414876 BOSTON MA 022414876 RESEARCH 125000 OHIO STATE UNIVERSITY 1960 KENNY ROAD COLUMBUS OH 43221 RESEARCH 125000 5 637304 1252458 1889762 PERMISSION FEES & OTHE 900099 5645 5645 5645 907 907 2310 2310 1898624 7955 0 907 X 875000 875000 181540 44130 78432 58978 213116 57501 107938 47677 128316 32920 60805 34591 37855 37855 13000 13000 952965 952965 1165 113 1052 18103 17166 937 37105 6387 23799 6919 PRINTING 44259 39961 4298 A/V 8413 8318 95 CATERING 5908 5908 HONORARIA 2000 2000 21545 16526 4586 433 2540290 2044669 346928 148693 2144855 1944177 904165 905072 439462 147500 2438 2375 3490920 2999124 30561 59677 30000 153000 128802 126556 189363 339233 X 767481 1111606 2534076 1548285 3301557 2659891 3490920 2999124 -641666 0 X X 0 1 X 1 0 X 757390 1902770 1667481 1798942 1252458 7379041 757390 1902770 1667481 1798942 1252458 7379041 3850689 3528352 2523 967 1110 1905 3217 9722 5645 5645 7394408 0.47720 0.43530 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 RELATED PARTY ACCOUNTS PAYABLE 126556 126556 1898624 0 1898624 0 1898624 2540290 0 2540290 0 2540290 1 CITY OF HOPE 1500 E DURATE ROAD DUARTE CA 910103000 953435919 501 (C)(3) 50000 RESEARCH JOHNS HOPKINS UNIVERSITY 733 N BROADWAY BALTIMORE MD 21205 520595110 501 (C)(3) 150000 RESEARCH MASS GENERAL HOSPITAL 101 HUNTINGDON AVENUE BOSTON MA 02199 042697983 501 (C)(3) 125000 RESEARCH MAYO CLINIC 200 FIRST STREET SW ROCHESTER MN 55905 416011702 501 (C)(3) 50000 RESEARCH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER 1960 KENNY ROAD COLUMBUS OH 43221 316401599 501 (C)(3) 125000 RESEARCH UNIVERSITY OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 48104 386006309 501 (C)(3) 150000 RESEARCH STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISO CA 941444253 941156365 501 (C)(3) 50000 RESEARCH FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 501 (C)(3) 50000 RESEARCH UNIVERSITY OF COLORADO PO BOX 910238 DENVER CO 802910238 846000555 501 (C)(3) 50000 RESEARCH VANDERBILT UNIVERSITY MEDICAL CENTER DEPARTMENT OF FINANCE AT40303 ATLANTA GA 311920303 620476822 501 (C)(3) 75000 RESEARCH 10 0 PART I, LINE 2 NCCN FOUNDATION HOLDS AN ANNUAL COMPETITIVE YOUNG INVESTIGATOR AWARD PROGRAM OPEN TO NOMINATED INVESTIGATORS AT THE 27 NCCN MEMBER INSTITUTIONS. IN COLLABORATION WITH THE NCCN FOUNDATION, THE NCCN ONCOLOGY RESEARCH PROGRAM (ORP) PROVIDES OVERSIGHT OF THIS PROGRAM AND THEIR STANDARDS ARE USED BY THE YIA GRANTS SCIENTIFIC REVIEW COMMITTEE TO REVIEW AND SCORE THE YIA PROPOSALS. THE FUNDED PROJECTS ARE APPROVED FOR TWO-YEAR TERMS AND ARE MANAGED BY THE ORP. INITIAL FUNDING IS PROVIDED BY THE NCCN FOUNDATION TO AWARDEES' INSTITUTIONS UPON THE RECEIPT OF APPLICABLE DOCUMENTS, INCLUDING INTERNAL REVIEW BOARD (IRB) APPROVAL DOCUMENTATION, A SIGNED TERM & CONDITIONS AGREEMENT ATTESTING THAT THE AWARDEES WILL ABIDE BY THE SPECIFIC TERMS OF THE AWARD, AN IRB-APPROVED PROTOCOL OR, IN THE CASE OF IRB EXEMPT RESEARCH, A RESEARCH PROJECT PLAN, HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA) DOCUMENTS RELATED TO THE PROJECT, A DATA MONITORING PLAN, PHYSICIAN PAYMENT TRANSPARENCY PROGRAM (SUNSHINE ACT) FORM, AND NCCN FINANCIAL CERTIFICATION/DISCLOSURE FORMS. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY AWARDEES ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE AWARDEES AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE YIA GRANTS SELECTION REVIEW COMMITTEE. SECOND-YEAR FUNDING IS PROVIDED TO THE AWARDEES' INSTITUTIONS UPON RECEIPT AND SATISFACTORY REVIEW OF AN ANNUAL PROGRESS REPORT, AN ANNUAL FINANCIAL REPORT, AND DOCUMENTATION OF CONTINUED APPLICABLE INSTITUTIONAL APPROVAL WITH THE FINAL GRANT PAYMENT PROVIDED UPON RECEIPT OF A COMPLETED GRANT RECONCILIATION AND FINAL STUDY REPORT. IF THE AWARDEE FAILS TO COMPLY WITH THE TERMS AND CONDITIONS OF THE AWARD AGREEMENT, OR OTHER CONTINGENCIES RECOMMENDED BY THE YIA GRANTS SCIENTIFIC REVIEW COMMITTEE, UNSPENT AWARD FUNDING MUST BE RETURNED WITHIN 60 DAYS TO NCCN FOUNDATION BY THE INSTITUTION. DURING THE TERM OF THE GRANT, INVESTIGATORS REPORT TO THE NCCN ONCOLOGY RESEARCH PROGRAM ON A QUARTERLY BASIS REGARDING THE STATUS AND PROGRESS OF THE FUNDED STUDIES. REPORTS INCLUDE AN ASSESSMENT OF OVERALL STUDY PROGRESS. X X 0 0 0 0 0 0 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 0 619349 0 94500 0 0 0 26500 0 35926 0 776275 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 0 373066 0 35750 0 0 0 26500 0 41926 0 477242 0 0 LISA KIMBRO CHIEF FINANCIAL OFFICER 0 287963 0 28937 0 0 0 26500 0 24521 0 367921 0 0 LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 0 248209 0 25000 0 0 0 25640 0 41781 0 340630 0 0 EILEEN BOSCIA CONTROLLER 0 162191 0 16254 0 0 0 10663 0 13117 0 202225 0 0 SUE MOST DIRECTOR, CLINICAL OPERATIONS 0 148539 0 4291 0 0 0 9934 0 23109 0 185873 0 0 FORM 990, PART VI, SECTION A, LINE 2 LISA KIMBRO IS THE CFO OF THE NCCN FOUNDATION. HER HUSBAND RAY LYNCH IS A BOARD MEMBER AND THE TREASURER OF THE NCCN FOUNDATION. FORM 990, PART VI, SECTION B, LINE 11B NCCN FOUNDATION PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN FOUNDATION REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN FOUNDATION'S EXECUTIVE DIRECTOR WILL BE REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIR OF THE NCCN BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2015. THE INFORMATION FROM THE SALARY SURVEY WILL BE FORWARDED TO THE NCCN CEO FOR HIS REVIEW. FORM 990, PART VI, SECTION B, LINE 15B: THE CHIEF EXECUTIVE OFFICER (CEO) IS A FULL TIME EMPLOYEE OF NCCN AND A PORTION OF HIS TIME IS ALLOCATED TO THE FOUNDATION. THE FOUNDATION RELIES ON NCCN FOR DETERMINATION AND REVIEW OF COMPENSATION. THE COMPENSATION OF NCCN'S (CEO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2015. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. THE CHIEF OPERATING OFFICER (COO) AND CHIEF FINANCIAL OFFICER (CFO) ARE FULL TIME EMPLOYEES OF NCCN AND A PORTION OF THEIR TIME IS ALLOCATED TO THE FOUNDATION. THE FOUNDATION RELIES ON NCCN FOR DETERMINATION AND REVIEW OF COMPENSATION. THE COMPENSATION OF NCCN'S COO AND CFO IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIR OF THE NCCN BOARD OF DIRECTORS. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2015. THE NCCN CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE OFFICERS OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 947,946. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 947,946. TRANSLATION SERVICES: PROGRAM SERVICE EXPENSES 5,019. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,019. FORM 990, PART XII, QUESTION 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NATIONAL COMPREHENSIVE CANCER NETWORK 275 COMMERCE DRIVE STE 300 FORT WASHINGTON PA 19034 232818395 CHARITABLE DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 NATIONAL COMPREHENSIVE CANCER NETWORK M 947946 FMV NATIONAL COMPREHENSIVE CANCER NETWORK O 637304 FMV PART V LINE 2 (C) SALARIES AND BENEFITS $522,971 PROFESSIONAL FEES 50,968 TRAVEL AND MEETINGS 47,173 OFFICE EXPENSE 3,410 SUPPLIES AND PRINTING 5,806 OTHER EXPENSES 3,626 MARKETING AND PUBLIC RELATIONS 1,465 TELEPHONE 1,885 TOTAL $637,304